A Study to Evaluate Usability of Subcutaneous Auto-injector of CT-P17 in Patients With Active Rheumatoid Arthritis

Condition:   Rheumatoid Arthritis Intervention:   Biological: CT-P17 SC AI (adalimumab) Sponsors:   Celltrion;   PPD Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials